Isleworth Healthcare Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on a business combination with a company in the healthcare industry. The company anticipates targeting companies domiciled in North America and Europe that are developing assets in the biopharmaceutical and medical technology/medical device space which aligns with its management team's experience in operating healthcare companies and in drug and device/technology development.
Company profile
Ticker
ISLE, ISLEW
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
ISLE stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
9 Sep 22
25-NSE
Exchange delisting
26 Aug 22
8-K
Other Events
26 Aug 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
DEF 14A
Definitive proxy
3 Aug 22
PRE 14A
Preliminary proxy
18 Jul 22
8-K
Isleworth and Cytovia Terminate Merger Agreement
30 Jun 22
425
Business combination disclosure
24 Jun 22
8-K
Regulation FD Disclosure
24 Jun 22
425
Business combination disclosure
10 Jun 22
Latest ownership filings
SC 13G
GLAZER CAPITAL, LLC
14 Feb 22
3
Monica P Reed
10 Sep 21
4
MARC D KOZIN
10 Sep 21
SC 13D
Isleworth Healthcare Sponsor I LLC
12 Mar 21
4
ROBERT S WHITEHEAD
3 Mar 21
3
McKenna Michelle
24 Feb 21
3
Vipul Patel
24 Feb 21
3
DAN L HALVORSON
24 Feb 21
3
MARC D KOZIN
24 Feb 21
3
Allen R Weiss
24 Feb 21
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 107.77 k | 107.77 k | 107.77 k | 107.77 k | 107.77 k | 107.77 k |
Cash burn (monthly) | 138.63 k | 38.98 k | (no burn) | (no burn) | 731.76 k | 521.31 k |
Cash used (since last report) | 3.00 mm | 844.59 k | n/a | n/a | 15.85 mm | 11.29 mm |
Cash remaining | -2.90 mm | -736.82 k | n/a | n/a | -15.75 mm | -11.19 mm |
Runway (months of cash) | -20.9 | -18.9 | n/a | n/a | -21.5 | -21.5 |
Institutional ownership, Q3 2022
19.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 83 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 50.92 mm |
Total shares | 5.07 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Isleworth Healthcare Sponsor I | 5.07 mm | $50.92 mm |